Skip to content
Open access

Association of mRNA SARS-CoV-2 vaccination with fatigue and functional recovery in patients with post-acute sequelae of COVID-19 (PASC).

Sep 2026 · Expert Review of Vaccines · Vol 25 1, pp. 2735166 · 0 citations · 28 references
Medicine

TL;DR

Fatigue and functional performance improved over time regardless of vaccination status, and there was no statistically significant association between mRNA SARS-CoV-2 vaccination and worsening symptoms or impaired recovery.

Abstract

Background

Patients with post-acute sequelae of SARS-CoV-2 (PASC) fear SARS-CoV-2 vaccine-linked symptom aggravation. Data on objective functional outcomes are limited.

Methods

We performed a retrospective analysis of an observational cohort at a post-COVID outpatient clinic at Hannover Medical School with standardized assessments at baseline and follow-up visit (3-6 months) in adults with confirmed SARS-CoV-2 infection and PASC. Participants were classified as vaccination (receipt of an additional SARS-CoV-2 vaccine dose between visits) or no vaccination. Primary outcomes were fatigue (Fatigue Assessment Scale) and exercise capacity (6-minute walk distance). Propensity scores matching (1:1 nearest-neighbor, ATT; caliper 0.2 SD) was performed using logistic regression. Group differences were assessed using t-tests/χ2 tests with Benjamini-Hochberg adjustment. Longitudinal changes were analyzed using linear mixed-effects models.

Results

Of 193 eligible patients, 174 were analyzed, 148 remained after matching (74 per group). No significant differences between the groups were observed at baseline or follow-up after adjustment for multiple comparisons. Both groups improved over time, with no statistically significant difference in fatigue or exercise capacity.

Conclusions

Fatigue and functional performance improved over time regardless of vaccination status. We found no statistically significant association between mRNA SARS-CoV-2 vaccination and worsening symptoms or impaired recovery, although smaller effects cannot be excluded.

Read PDF

Similar papers

Open access Sep 2026

Five-Year Effectiveness and Adherence Outcomes of SARS-CoV-2 Vaccination in Immunocompromised Patients Since the Launch of the Vaccination Campaign

Background: Immunocompromised patients are at heightened risk for severe COVID-19 and its complications. While vaccination is critical for this population, long-term adherence and the durability of vaccine-induced immunity remain significant public health concerns. This study aimed to evaluate the longitudinal serologi...

A. Sarcone, Maria Rosaria Deodato, A. De Pasquale et al. · 0 citations
Open access Sep 2026

Age-specific humoral immune response to SARS-CoV-2: A comparative analysis of antibody levels in children and adults after vaccination with primary series or infection

COVID-19 immune responses differ between children and adults, with adolescents exhibiting stronger immune response to vaccination than children younger than 12, however vaccine dosage may play a role in this observed difference.

Brooke A. Hawkes, J. Hollister, Cynthia Porter et al. · 0 citations
Review Open access Oct 2026

Factors associated with persistent post-COVID-19 condition and functional limitation four years after SARS-CoV-2 infection

Post-COVID-19 condition (PCC) can persist for years after acute SARS-CoV-2 infection, but factors associated with long-term persistence and functional outcomes remain incompletely understood. In this longitudinal cohort study, adults with confirmed SARS-CoV-2 infection who had volunteered for plasma donation completed...

M. Faraj, A. Grosshennig, N. Goedecke et al. · 0 citations
Open access Sep 2026

Associations of age, COVID-19 vaccination, and SARS-CoV-2 infection history with health-related quality of life in a community-based longitudinal cohort in Singapore.

Older adults had lower HR-QoL across multiple domains, whereas younger participants showed lower HR-QoL primarily during the early post-infection period, whereas younger participants showed lower HR-QoL primarily during the early post-infection period.

Zhi-Lian Huang, Alexius Matthias Se Soh, Kang-Wei Zeng et al. · 0 citations
Open access Sep 2026

Assessing SARS-CoV-2 immune markers in vaccinated asymptomatic adults after household exposure in Canada (AB-PROTECT): a prospective cohort study.

Early after household exposure, binding and neutralising antibodies were similar in all participants, but differences in T-cell functional responses were evident in individuals who developed symptoms after SARS-CoV-2 infection.

Christopher Kandel, Jessica A. Breznik, Maureen Taylor et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.